Alterations of nasal mucociliary clearance in association with HIV infection and the effect of guaifenesin therapy

Laryngoscope

Volumn 115, Issue 1 I, 2005, Pages 27-30

  Rosen, Elizabeth J ^a,c   Calhoun, Karen H ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIFENESIN; SACCHARIN;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MUCOCILIARY CLEARANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; EXPECTORANTS; FEMALE; GUAIFENESIN; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; NASAL MUCOSA; SACCHARIN; SINUSITIS;

EID: 11844301307     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000150678.83602.d4     Document Type: Review

References (15)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2002;14:1-40.
2. Belafsky P, Kissinger P, Davidowitz SB, Amedee RG. HIV sinusitis: rationale for a treatment algorithm. J La State Med Soc 1999;151:11-18.
3. Rubin JS, Honigberg R. Sinusitis in patients with the acquired immunodeficiency syndrome. Ear Nose Throat J 1990;69:460-463.
4. Milgrim LM, Rubin JS, Small CB. Mucociliary clearance abnormalities in the HIV-infected patient: a precursor to acute sinusitis. Laryngoscope 1995;105:1202-1208.
5. Wawrose SF, Tami TA, Amoils CP. The role of guaifenesin in the treatment of sinonasal disease in patients infected with the human immunodeficiency virus (HIV). Laryngoscope 1992;102:1225-1228.
6. Andersen I, Camner P, Jensen PL, et al. A comparison of nasal and tracheobronchial clearance. Arch Environ Health 1974;29:290-293.
7. Rutland J, Cole PJ. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax 1981;36:654-658.
8. Jorissen M. Correlations among mucociliary transport, ciliary function, and ciliary structure. Am J Rhinol 1998;12: 53-58.
9. Outzen KE, Svane-Knudsen V. Effect of surface-active substance on nasal mucociliary clearance time: a comparison of saccharin clearance time before and after the use of surface-active substance. Rhinology 1993;31:155-157.
10. Majima Y, Sakakura Y, Matsubara T, Miyoshi Y. Possible mechanisms of reduction of nasal mucociliary clearance in chronic sinusitis. Clin Otolaryngol 1986;11:55-60.
11. Hady MR, Shehata O, Hassan R. Nasal mucociliary function in different diseases of the nose. J Laryngol Otol 1983;97: 497-502.
12. Karlsson G, Hansson HA, Petruson B, Bjorkander J. The nasal mucosa in immunodeficiency. Surface morphology, mucociliary function and bacteriological findings in adult patients with common variable immunodeficiency or selective IgA deficiency. Acta Otolaryngol 1985;100:456-469.
13. Tami TA. The management of sinusitis in patients infected with the human immunodeficiency virus (HIV). Ear Nose Throat J 1995;74:360-363.
14. Anderson ER, Murphy MP, Weymuller EA Jr. Clinometric evaluation of the Sinonasal Outcome Test-16. Student Research Award 1998. Otolaryngol Head Neck Surg 1999; 121:702-707.
15. Sisson JH, Yonkers AJ, Waldman RH. Effects of guaifenesin on nasal mucociliary clearance and ciliary beat frequency in healthy volunteers. Chest 1995;107:747-751.